SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0000886163-24-000021
Filing Date
2024-04-25
Accepted
2024-04-24 19:32:36
Documents
4

Document Format Files

Seq Description Document Type Size
1 DEFA14A ligand-2024proxysupplement.htm DEFA14A 9825
2 meetingnotice1of2.jpg GRAPHIC 318311
3 meetingnotice2of2.jpg GRAPHIC 280642
4 newligandlogo.jpg GRAPHIC 43732
  Complete submission text file 0000886163-24-000021.txt   894882
Mailing Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121
Business Address 3911 SORRENTO VALLEY BLVD SUITE 110 SAN DIEGO CA 92121 858-550-7500
LIGAND PHARMACEUTICALS INC (Filer) CIK: 0000886163 (see all company filings)

IRS No.: 770160744 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEFA14A | Act: 34 | File No.: 001-33093 | Film No.: 24872344
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)